Abstract:

Since after World War II, the world has been grappling with the grumbling rising prevalence and economic burden of non-communicable diseases (NCDs). The rise of these chronic diseases has reached an epidemic proportion and a melting point in many communities of the world. This has been made worse by the recent COVID-19 pandemic. While the world is still battling this debilitating reality, a more gruesome scenario is evolving in low-income and Middle-Income Countries (LMICs). Although these countries account for the highest poverty index in the world, they also account for a disproportionately higher burden of NCDs. More than 80% of NCD-related deaths are presently recorded among the LMICs. Ironically, although most sub-Saharan Africa (SSA) countries can be categorized as LMICs, yet communicable diseases (CDs) still constitute the highest disease burden in this region. However, based on global projections, SSA may soon lose this ‘advantage’ and may become the region with the highest burden of NCDs by the year 2030. If the present trajectory is left unshattered, the resulting heavy double burden of CDs and NCDs will likely crumble the already fragile economy of most SSA countries and tilt the region into an unprecedented recession. A critical review of the present disease-centered healthcare management approach and adoption of a more evidence-based health promotion-centered management approach may be vital in salvaging the situation. This article briefly reviewed the global epidemiologic transition, compared the disease- and health promotion-centered healthcare models, and made a case for a change in health management strategy in SSA.

Keywords: Disease-centered approach, Epidemiological transition, Health promotion-centered approach, lifestyle modification, Non-communicable Diseases Risk factors, sub-Saharan Africa.

References:

[1] Diehl H., 2011, Modern Medicine: Miracles, Medicines, Money & Mirages, Lifestyle Medicine Institute of Loma Linda California Press, pp 1 – 14.

[2] McKeown R.E., 2009, The Epidemiologic Transition: Changing Patterns of Mortality and Population Dynamics, Am J Lifestyle Med., 3(1 Suppl), 19S–26S.

https://doi:10.1177/1559827609335350.

[3] Sarukhan A., 2018, The Epidemiological Transition (or What We Died, Die and Will Die From). Barcelona Institute for Global Health (ISGlobal), Date of access: 3/2/2021. https://www.isglobal.org/en/healthisglobal/-/custom-blog-portlet/la-transicion-epidemiologica-o-de-que-moriamos-morimos-y-moriremos-/3098670/0.

[4] Ipsum L., 2021, The epidemiological transition. London School of Hygiene & Tropical Medicine, Date of access: 3/2/21. https://www.futurelearn.com/info/courses/public-health-history/0/steps/30337.

[5] Schettler G., 1983, Atherosclerosis during periods of food deprivation following world wars I and II, Preventive Medicine, 12 (1), 75 – 83. https://doi.org/10.1016/0091-7435(83)90174-3.

[6] World Health Organization, 2020, Non-communicable diseases progress monitor 2020, World Health Organization, Date of access: 7/3/2021. https://apps.who.int/iris/handle/10665/330805.

[7] World Health Organization, 2018, Non-communicable Diseases Country profiles 2018, World Health Organization, Date of access: 5/2/2019. https://www.who.int/nmh/publications/ncd-profiles-2018/en/.

[8] Ambrosino I., Barbagelata E., Ortona E., Ruggieri A., Massiah G., Giannico O.V., et al., 2020, Gender differences in patients with COVID-19: a narrative review. Monaldi Archives for Chest Disease, 90 (1389), 318-24.

[9] Bonyan F.A., Shareef L.G., Al-waily A., Abdulrazaq A.A., and Al-Rubayee W.A., 2020, COVID-19 clinical characteristics and outcomes in 60 hospitalized Iraqi patients - Case series. Medical Science, 24(104), 2251-58.

[10] Ezzati M., Hoorn S.V., Lawes C.M.M., Leach R, James W.P.T., Lopez A.D., et al., 2005, Rethinking the ‘‘Diseases of Affluence’’ Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development. PLoS Medicine, 2 (5), 404-12.

[11] World Health Organization, 2005, Rethinking “diseases of affluence” the economic impact of chronic diseases. World Health Organization, Date of access: 12/3/2021

https://www.who.int/chp/chronic_disease_report/media/Factsheet4.pdf?ua=1.

[12] Bloom D.E., Cafiero E.T., and Jané-Llopis E., Abrahams-Gessel S., Bloom L.R., Fathima S., et al., 2011, The Global Economic Burden of Noncommunicable Diseases. World Economic Forum, Date of access: 5/7/2018. http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf.

[13] World Health Organization, 2011, Global Status Report on Non-Communicable Diseases 2010. World Health Organization. Date of access: 5/7/2018. https://www.who.int/nmh/publications/ncd_report_full_en.pdf.

[14] Boutayeb A., 2010, The Burden of Communicable and Non-Communicable Diseases in Developing Countries. In: Preedy V.R., Watson R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures, Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_32.

[15] Sibai A., Tohme R.A., Mahfoud Z., Chaaya M., and Hwalla N., 2009, Non-communicable Diseases and Behavioral Risk Factor Survey: Comparison of estimates based on cell phone interviews with face-to-face interviews, World Health Organization- Lebanon office.

[16] World Health Organization, 2008, Executive summary: 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Non - communicable Diseases Report 2008, World Health Organization, Date of access: 30/4/2021. https://www.who.int/nmh/publications/ncd_action_plan_en.pdf.

[17] Cooper R.S., Amoah A.G., and Mensah G.A., 2003, High blood pressure: the foundation for epidemic cardiovascular disease in African populations, Ethn Dis., 13, 48 – 52.

[18] Bonita R., Beaglehole R., and Kjellström T., 2006, Basic epidemiology, 2^nd edition, World Health Organization, Date of access: 3/4/2020. https://apps.who.int/iris/bitstream/handle/10665/43541/9241547073_eng.pdf?sequence=1&isAllowed=y.

[19] Akinlua J.T., Meakin R., Umar A.M, and Freemantle N., 2015, Current Prevalence Pattern of Hypertension in Nigeria: A Systematic Review, PLoS ONE, 10, 0140021.

[20] Ogah O. S., and Rayner B.L., 2013, Recent advances in hypertension in sub-Saharan Africa. Heart, 0, 1 – 8. https://Doi:10.1136/heartjnl-2012-303227.

[21] Federal Ministry of Health of Nigeria, 2015, National Strategic Plan of Action on Prevention and Control of Non-Communicable Diseases, Federal Ministry of Health – Nigeria, Date of access: 12/6/2018.

www.medbox.org/Nigeria-national...prevention-and-control...noncommunicablediseases.pdf.

[22] Dalal S., Beunza J.J., Volmink J., Adebamowo C., Bajunirwe F., Njelekela M., et al., 2011, non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol., 40: 885-901.

[23] Groves J., 2010, International Alliance of Patients’ Organizations perspectives on person-centered medicine. International Journal of Integrated Care, 10, 27-29. ISSN 1568-4156. URL: http://www.ijic.org.

[24] Roy M., Levasseur M., Couturier Y., Lindströme B., and Généreux M., 2015, The relevance of positive approaches to health for patient-centered care medicine. Preventive Medicine Reports, 2, 10 – 12. http://dx.doi.org/10.1016/j.pmedr.2014.11.005.

[25] Chawla N.V., and Davis D.A., 2013, Bringing Big Data to Personalized Healthcare: A Patient-Centered Framework. J Gen Intern Med, 28(Suppl 3): S660–5. http://DOI:10.1007/s11606-013-2455-8.

[26] Wu F., Narimatsu H., Li X., Nakamura S., Sho R., Zhao G, et al., 2017, non-communicable diseases control in China and Japan. Globalization and Health, 13, 91. http://DOI:10.1186/s12992-017-0315-8.

[27] World Health Organization, 2020, Assessing national capacity for the prevention and control of non-communicable diseases: report of the 2019 global survey, World Health Organization, Date of access: 14/3/2021.https://www.who.int/publications/i/item/ncd-ccs-2019.

[28] United Nations, 2011, Draft Resolution Submitted by the President of the General Assembly: Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases, United Nations, Date of access: 30/4/2021.

https://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf.

[29] World Health Organization, 2009, Milestones in Health Promotion: Statements from Global Conferences, World Health Organization, Date of access: 30/4/2021.

https://www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pdf.

[30] World Health Organization, 2004, National Action Plan for Prevention and Control of Non-Communicable Diseases and Health Promotion in Pakistan: A Public-Private Partnership in Health, World Health Organization, – WHO Report 2004; 1 – 141.

[31] Okafor C.N., Young E.E., Nwobi A.E., 2016, Health promotion strategies for the prevention and control of non-communicable diseases in Nigeria. South American Journal of Public Health, 4(1), 1 – 10.